Invention Grant
- Patent Title: Thienopyridine derivative for the treatment of hepatitis C infections
-
Application No.: US15212703Application Date: 2016-07-18
-
Publication No.: US09937160B2Publication Date: 2018-04-10
- Inventor: Karl Roberts , Geena Malhotra , Dhiraj Abhyankar , Kalpana Joshi , Jeevan Ghosalkar
- Applicant: Cipla (UK) Limited
- Applicant Address: IN Mumbai
- Assignee: Cipla (UK) Limited
- Current Assignee: Cipla (UK) Limited
- Current Assignee Address: IN Mumbai
- Agency: Meunier Carlin & Curfman LLC
- Priority: IN2691/MUM/2015 20150716
- Main IPC: A61K31/44
- IPC: A61K31/44 ; A61K31/4365 ; A61K45/06
Abstract:
The present invention relates to methods of treatment of hepatitis C using prasugrel. The methods of the present invention can be used in patients with hepatitis C administering prasugrel in combination with one or more anti-hepatitis C drugs.
Public/Granted literature
- US20170014394A1 THIENOPYRIDINE DERIVATIVE FOR THE TREATMENT OF HEPATITIS C INFECTIONS Public/Granted day:2017-01-19
Information query
